BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38505869)

  • 1. microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB.
    Sun G; Ni K; Shen J; Liu D; Wang H
    Crit Rev Eukaryot Gene Expr; 2024; 34(4):13-23. PubMed ID: 38505869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Regulation of let-7c-5p on the Biological Characteristics of Lung Adenocarcinoma Cells by Targeting AURKB.
    Wang L; Xiao X; Du H
    Mol Biotechnol; 2022 May; 64(5):526-534. PubMed ID: 34997902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
    Han J; Wang Y
    Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7c-5p Represses Cisplatin Resistance of Lung Adenocarcinoma Cells by Targeting CDC25A.
    Huang L; Lou K; Wang K; Liang L; Chen Y; Zhang J
    Appl Biochem Biotechnol; 2023 Mar; 195(3):1644-1655. PubMed ID: 36355336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.
    Zhou Y; Yan J; Chen H; Zhou W; Yang J
    Cells Tissues Organs; 2024; 213(1):55-66. PubMed ID: 36273455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
    Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
    Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
    Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
    Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
    Xu J
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
    Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
    Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-9-5p Facilitates Lung Adenocarcinoma Cell Malignant Progression via Targeting STARD13.
    Lu Y; Zheng W; Rao X; Du Y; Xue J
    Biochem Genet; 2022 Dec; 60(6):1865-1880. PubMed ID: 35119587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
    Liu B; Wang R; Liu H
    Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor E2F8 activates PDK1-mediated DNA damage repair to enhance cisplatin resistance in lung adenocarcinoma.
    Li H; Sun J; Hu H; Wang Y
    Pharmacology; 2024 May; ():. PubMed ID: 38810606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
    Du H; Li Y; Sun R; Yuan Y; Sun S; Zhang Y
    Thorac Cancer; 2020 Sep; 11(9):2473-2482. PubMed ID: 32648688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis.
    Yu N; Gong H; Chen W; Peng W
    Thorac Cancer; 2023 Jun; 14(16):1467-1476. PubMed ID: 37105934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
    Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
    Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.
    Li J; He X; Wu X; Liu X; Huang Y; Gong Y
    Comput Math Methods Med; 2020; 2020():2953598. PubMed ID: 33204298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.